We've found
25,125
archived clinical trials in
Diabetes
We've found
25,125
archived clinical trials in
Diabetes
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
Updated: 11/13/2017
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
Updated: 11/13/2017
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Click here to add this to my saved trials

Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
Updated: 11/13/2017
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
Updated: 11/13/2017
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Click here to add this to my saved trials

Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
Updated: 11/13/2017
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
Updated: 11/13/2017
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Click here to add this to my saved trials

Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
Updated: 11/13/2017
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
Updated: 11/13/2017
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Enrolling
Updated: 11/13/2017
Click here to add this to my saved trials

The Relationship of Hemoglobin A1c and Diabetic Wound Healing
Updated: 11/13/2017
The Relationship of Hemoglobin A1c and Diabetic Wound Healing
Status: Enrolling
Updated: 11/13/2017
The Relationship of Hemoglobin A1c and Diabetic Wound Healing
Updated: 11/13/2017
The Relationship of Hemoglobin A1c and Diabetic Wound Healing
Status: Enrolling
Updated: 11/13/2017
Click here to add this to my saved trials

Pioglitazone on Pancreatic Steatosis and Bone Health
Updated: 11/14/2017
Effect of Pioglitazone on Pancreatic Steatosis and Bone Health
Status: Enrolling
Updated: 11/14/2017
Pioglitazone on Pancreatic Steatosis and Bone Health
Updated: 11/14/2017
Effect of Pioglitazone on Pancreatic Steatosis and Bone Health
Status: Enrolling
Updated: 11/14/2017
Click here to add this to my saved trials

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Updated: 11/16/2017
A Double-blind [Sponsor Unblinded], Randomized, Placebo-controlled, Staggered-parallel Study to Investigate the Safety, Tolerability, and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/16/2017
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Updated: 11/16/2017
A Double-blind [Sponsor Unblinded], Randomized, Placebo-controlled, Staggered-parallel Study to Investigate the Safety, Tolerability, and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/16/2017
Click here to add this to my saved trials

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Updated: 11/16/2017
A Double-blind [Sponsor Unblinded], Randomized, Placebo-controlled, Staggered-parallel Study to Investigate the Safety, Tolerability, and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/16/2017
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Updated: 11/16/2017
A Double-blind [Sponsor Unblinded], Randomized, Placebo-controlled, Staggered-parallel Study to Investigate the Safety, Tolerability, and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/16/2017
Click here to add this to my saved trials

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Updated: 11/16/2017
A Double-blind [Sponsor Unblinded], Randomized, Placebo-controlled, Staggered-parallel Study to Investigate the Safety, Tolerability, and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/16/2017
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Updated: 11/16/2017
A Double-blind [Sponsor Unblinded], Randomized, Placebo-controlled, Staggered-parallel Study to Investigate the Safety, Tolerability, and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/16/2017
Click here to add this to my saved trials

Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Click here to add this to my saved trials

Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Click here to add this to my saved trials

Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Click here to add this to my saved trials

Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Click here to add this to my saved trials

Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Click here to add this to my saved trials

Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Click here to add this to my saved trials

Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Updated: 11/16/2017
Epidemiology of Diabetes Interventions and Complications (EDIC)
Status: Enrolling
Updated: 11/16/2017
Click here to add this to my saved trials

A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects
Updated: 11/16/2017
A Phase I, First In Human, Double Blind, Placebo Controlled, Single Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Interaction Effect With Metformin Following A Single Oral Dose Of DA-1241 In Healthy Male Subjects
Status: Enrolling
Updated: 11/16/2017
A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects
Updated: 11/16/2017
A Phase I, First In Human, Double Blind, Placebo Controlled, Single Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Interaction Effect With Metformin Following A Single Oral Dose Of DA-1241 In Healthy Male Subjects
Status: Enrolling
Updated: 11/16/2017
Click here to add this to my saved trials

Changes in Ectopic Fat Following Surgically Induced Weight Loss
Updated: 11/17/2017
Changes in Ectopic Fat Following Surgically Induced Weight Loss: Does it Explain the Resolution of Diabetes?
Status: Enrolling
Updated: 11/17/2017
Changes in Ectopic Fat Following Surgically Induced Weight Loss
Updated: 11/17/2017
Changes in Ectopic Fat Following Surgically Induced Weight Loss: Does it Explain the Resolution of Diabetes?
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials

Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)
Updated: 11/17/2017
Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/17/2017
Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)
Updated: 11/17/2017
Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials

Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
Updated: 11/17/2017
Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/17/2017
Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
Updated: 11/17/2017
Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials

A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Updated: 11/20/2017
Safety, Tolerability, Pharmacokinetics, and Efficacy of LY3053102 With 12 Weeks of Treatment in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Updated: 11/20/2017
Safety, Tolerability, Pharmacokinetics, and Efficacy of LY3053102 With 12 Weeks of Treatment in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Updated: 11/20/2017
Safety, Tolerability, Pharmacokinetics, and Efficacy of LY3053102 With 12 Weeks of Treatment in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Updated: 11/20/2017
Safety, Tolerability, Pharmacokinetics, and Efficacy of LY3053102 With 12 Weeks of Treatment in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Updated: 11/20/2017
Safety, Tolerability, Pharmacokinetics, and Efficacy of LY3053102 With 12 Weeks of Treatment in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Updated: 11/20/2017
Safety, Tolerability, Pharmacokinetics, and Efficacy of LY3053102 With 12 Weeks of Treatment in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Updated: 11/20/2017
Safety, Tolerability, Pharmacokinetics, and Efficacy of LY3053102 With 12 Weeks of Treatment in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Updated: 11/20/2017
Safety, Tolerability, Pharmacokinetics, and Efficacy of LY3053102 With 12 Weeks of Treatment in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Updated: 11/20/2017
Safety, Tolerability, Pharmacokinetics, and Efficacy of LY3053102 With 12 Weeks of Treatment in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Updated: 11/20/2017
Safety, Tolerability, Pharmacokinetics, and Efficacy of LY3053102 With 12 Weeks of Treatment in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
Updated: 11/20/2017
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
